The 8th Annual BIO Investor Forum
October 28-29, 2009
Palace Hotel
San Francisco, CA
A National Forum Featuring Late-Stage Private and Emerging Public Companies
Advisory Committee
| Graeme Martin, PhD | Takeda Research Investments, Inc. |
| Evan McCulloch, CFA | Franklin Templeton Investments |
| Mark Schoenbaum, MD | Deutsche Bank |
| Paul Wagner, CFA | RCM Capital Management LLC |
Click here to read about the Advisory Committee
Highlights:
- More than 110 late-stage private & emerging public company presentations
- Therapeutic panels led by clinical thought leaders
- Business roundtables addressing key issues affecting biotech executives
- Partnering meetings
- Networking opportunities investors and industry executives focused exclusively on biotechnology
Who Should Attend
Public and private equity investors, research analysts, investment bankers, and industry executives focused on investment and business development opportunities in the life sciences.
Investors attend to:
- hear from and meet with executives at the top life sciences growth companies
- benefit from candid panel discussions with leading clinical experts and investigators with insights on pipeline research and clinical practice
- get a ‘big picture’ overview of the industry and the issues affecting product innovation, capitalization, and commercialization
- meet one-on-one with new and current investors, analysts, and partnering companies
- get the pulse on the latest life sciences investment trends from sophisticated investment and company executives
- showcase your company story in presentations to qualified investors
- network with peers, investors and potential partners
For more information, please contact customer service:
Email: biopartnering@bio.org
Phone: 866.356.5155, +1.202.962.6666
Please return to this site to view updated information.